Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer. Clin Cancer Res. 2011 Jan 15; 17(2):372-81.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Biomarkers, Tumor
Breast Neoplasms
Capecitabine
Clinical Trials, Phase III as Topic
Deoxycytidine
Disease-Free Survival
Fluorouracil
Humans
Middle Aged
Neoplasm Metastasis
Neuropilin-1
Vascular Endothelial Growth Factor C
authors with profiles
Melody Cobleigh